NASDAQ:APTO
Aptose Biosciences Stock News
$1.22
+0.0600 (+5.17%)
At Close: Apr 26, 2024
Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021
04:02pm, Monday, 26'th Apr 2021
SAN DIEGO and TORONTO, April 26, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the under
5 Red-Hot Stocks to Buy Now Trading Under $10 With Abundant Upside Potential
06:15am, Saturday, 17'th Apr 2021
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Aptose to Present at Canaccord Genuity 2021 Horizons in Oncology Virtual Conference
07:30am, Thursday, 08'th Apr 2021
SAN DIEGO and TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the under
Aptose Provides An Encouraging Update, But The Road Ahead Is Still Long
11:50am, Thursday, 25'th Mar 2021
Aptose offered a clinical update with its fourth quarter earnings report that included no new safety/toxicity concerns for luxeptinib, suggesting prior signals were one-offs unrelated to the drug. A c
APTO Stock Price Increased 66.21%: Why It Happened
08:43pm, Wednesday, 24'th Mar 2021
The stock price of Aptose Biosciences Inc (NASDAQ: APTO) has increased by 66.21% today. This is why it happened.
Aptose Biosciences Stock Trades Higher After Q4 Earnings: Technical Levels To Watch
05:10pm, Wednesday, 24'th Mar 2021
Aptose Biosciences Inc. (NASDAQ: APTO) shares traded higher after the company's release of fourth-quarter results Tuesday. The stock gained 66.21% in Wednesday's regular session, closing at $6.10.
Why Aptose Biosciences Stock Is Skyrocketing Today
12:25pm, Wednesday, 24'th Mar 2021
The company reported very encouraging results from an early-stage study.
APTO Stock: Why Aptose Biosciences Is Rocketing Higher Today
11:46am, Wednesday, 24'th Mar 2021
APTO stock is rocketing this morning as the company releases some encouraging research details alongside its Q4 earnings report. The post APTO Stock: Why Aptose Biosciences Is Rocketing Higher Today a
APTO Stock Price Increases Over 25% Pre-Market: Why It Happened
06:06am, Wednesday, 24'th Mar 2021
The stock price of Aptose Biosciences Inc (NASDAQ: APTO) has increased by over 25% pre-market. This is why it happened.
Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2020 Results - Earnings Call Transcript
11:48pm, Tuesday, 23'rd Mar 2021
Aptose Biosciences Inc. (APTO) CEO William Rice on Q4 2020 Results - Earnings Call Transcript
Aptose Reports Results for the Fourth Quarter and Full Year 2020
04:01pm, Tuesday, 23'rd Mar 2021
- Conference call and webcast at 5pm EDT today -
Aptose Expands Senior Leadership Team
07:30am, Tuesday, 16'th Mar 2021
George Melko, Pharm.D. joins as Vice President, Regulatory Affairs
Aptose Biosciences (APTO) Sees Hammer Chart Pattern: Time to Buy?
08:17am, Wednesday, 30'th Dec 2020
Aptose Biosciences (APTO) has been struggling lately, but the selling pressure may be coming to an end soon.
Aptose Shares Sell Off As The Market Wanted More Than Further Signs And Portents
10:19am, Tuesday, 08'th Dec 2020
Aptose shares are weak in post-ASH trading as the Phase I CG-806 study has yet to produce a clinical response in B-cell malignancies. Three B-cell patients did see some tumor reduction at lower doses
Aptose Presents Highlights from ASH and Corporate Update Event
05:30pm, Sunday, 06'th Dec 2020
SAN DIEGO and TORONTO, Dec. 06, 2020 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (NASDAQ: APTO, TSX: APS) today released highlights from a corporate update event held on Sunday, Decembe
